- OVERNIGHT HEALTH: Senate passes Prescription Drug User Fee Act 96-1
The Senate overwhelmingly passed a major Food and Drug Administration reauthorization on Thursday after defeating more controversial amendments designed to lower the price of prescription drugs.
The bill, which reauthorizes user fees the Food and Drug Administration collects from drug and device companies, passed 96-1. Sen. Bernie Sanders (I-Vt.) was the only “no” vote. There’s also broad bipartisan support for the House version, which cleared the Energy and Commerce Committee by a voice vote and is awaiting a vote on the floor.
Both bills would reauthorize existing user fees and create a new fee for companies that make generic drugs. The firms have complained about long backlogs of applications at the FDA, leading to delayed approvals.
Senate Majority Leader Harry Reid (D-Nev.) praised Sens. Tom Harkin (D-Iowa) and Mike Enzi (R-Wyo.) for their bipartisan work to get the bill out of committee quickly and easily.
“It’s exemplary for what the rest of us should do. I appreciate very much the work they have done. I repeat, it’s how we should get other work done,” Reid said.
- Senate passes FDA reauthorization
Sen. Reid praised the work of the bill’s sponsors as “exemplary for what the rest of us should do.”
- Senate defeats McCain amendment on Canadian pharmacies
The Senate defeated an amendment that would have let Americans buy drugs from Canadian pharmacies.
- Senate Republicans criticize Obama as drug reimportation amendment fails
Sen. Grassley said Obama “shouldn’t have made a deal with the pharmaceutical companies on ObamaCare two years ago.”
Digest powered by RSS Digest